APA (7th ed.) Citation

Richard Burt, Dana Warcel, & Adele K. Fielding. (2019). Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Richard Burt, Dana Warcel, and Adele K. Fielding. Blinatumomab, a Bispecific B-cell and T-cell Engaging Antibody, in the Treatment of B-cell Malignancies. Taylor & Francis Group, 2019.

MLA (9th ed.) Citation

Richard Burt, et al. Blinatumomab, a Bispecific B-cell and T-cell Engaging Antibody, in the Treatment of B-cell Malignancies. Taylor & Francis Group, 2019.